August 29, 2024

New algorithm facilitates personalized treatments for genetic disorders and cancer

The RTD detective computational model, developed by CRG researchers and published in Nature Genetics, predicts the efficacy of drugs for pathologies caused by genetic mutations. Based on data from more than 5000 patients, the system promises to accelerate the development of targeted therapies and optimize clinical trials.
August 28, 2024

Conference “Promotion of cardiovascular health in the work environment” in Zaragoza

Ibercaja Foundation, in collaboration with the Aragón Health Research Institute (IIS Aragón), presents on October 3 the conference “Promotion of cardiovascular health in the work environment”, with the aim of raising awareness and promoting the importance of promoting health at work, valuing its benefits.
August 27, 2024

Marta Lalinde: “Childhood cancer research is a great challenge that needs time and resources”

Marta Lalinde is the clinical trials coordinator of the Pediatric Oncohematology Unit of the Miguel Servet Children's Hospital in Zaragoza. She has been in this newly created position for two and a half years, which is funded equally by Aspanoa and IIS Aragón.
August 26, 2024

RNA 'sequestration' silences the development of acute myeloid leukemia

An international study, published in the journal Nature Cell Biology, offers a new perspective to better understand the malignant transformation of cells that occurs in this disease.
August 22, 2024

A research project seeks to reduce childhood obesity with the help of one hundred families in Aragon

The IIS Aragón has been collaborating since 2019 in the 'Meli-POP' study to prevent childhood obesity. We work with children who were then between 3 and 6 years old and who will be followed up until adolescence.
August 21, 2024

Gracia Mendoza Cantos: “Scientific knowledge is generated with determination, patience and imagination”

In this interview, the IIS Aragón researcher talks about her work leading the 'AMIB: Advanced Materials in Biomedicine' Group (GIIS102), and what her day-to-day life is like.
August 20, 2024

The magazine Cancers highlights a review article on therapies from the Molecular Oncology group of the IIS Aragón

The work has been dedicated to Professor María Victoria Arruga, who recently died, and who was the "teacher" of the researcher Alberto J. Schuhmacher. The article was one of the five highlighted among the 157 in the latest issue of the magazine on its website.
August 19, 2024

An innovative project seeks to improve health from Aragon: "If they call you, come"

The IIS Aragón participates in the Impact Cohort project, which will follow 8.000 Aragonese (200.000 throughout Spain) for 20 years to prevent and treat diseases. The Monzón node has already attracted more than 300 participants.
August 14, 2024

A large genomic map of colorectal cancer seeks to improve its treatment

The development of this atlas has been possible thanks to the complete genome sequencing of 2023 colon tumors. The data generated from the analysis is accessible to the scientific community.